作者
Massimo Radin, Savino Sciascia, Doruk Erkan, Vittorio Pengo, Maria G Tektonidou, Amaia Ugarte, Pierluigi Meroni, Lanlan Ji, H Michael Belmont, Hannah Cohen, Guilherme Ramires de Jesús, D Ware Branch, Paul R Fortin, Laura Andreoli, Michelle Petri, Esther Rodriguez, Ignasi Rodriguez-Pinto, Jason S Knight, Tatsuya Atsumi, Rohan Willis, Emilio Gonzalez, Rosario Lopez-Pedrera, Ana Paula Rossi Gandara, Margarete Borges Gualhardo Vendramini, Alessandra Banzato, Ecem Sevim, Medha Barbhaiya, Maria Efthymiou, Ian Mackie, Maria Laura Bertolaccini, Danieli Andrade, APS ACTION
发表日期
2019/12/1
期刊
Seminars in arthritis and rheumatism
卷号
49
期号
3
页码范围
464-468
出版商
WB Saunders
简介
Objectives
To assess whether patients with antiphospholipid syndrome (APS) and history of recurrent thrombosis have higher levels of adjusted Global AntiphosPholipid Syndrome Score (aGAPSS) when compared to patients without recurrent thrombosis.
Methods
In this cross-sectional study of antiphospholipid antibody (aPL)-positive patients, we identified APS patients with a history of documented thrombosis from the AntiPhospholipid Syndrome Alliance For Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository (“Registry”). Data on aPL-related medical history and cardiovascular risk factors were retrospectively collected. The aGAPSS was calculated at Registry entry by adding the points corresponding to the risk factors: three for hyperlipidemia, one for arterial hypertension, five for positive anticardiolipin antibodies, four for positive anti-β2 glycoprotein-I antibodies and four …
学术搜索中的文章
M Radin, S Sciascia, D Erkan, V Pengo… - Seminars in arthritis and rheumatism, 2019
M Radin, L Bertero, D Roccatello, S Sciascia - Semin Arthritis Rheum, 2019